World Journal of Biological Psychiatry

Papers
(The TQCC of World Journal of Biological Psychiatry is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood78
The biology of burnout: Causes and consequences55
Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance43
The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe41
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?38
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders37
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders36
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis35
Personalising transcranial magnetic stimulation for depression using neuroimaging: A systematic review33
Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyl30
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD23
Lifetime and current depression in the German National Cohort (NAKO)23
Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia20
Microglia and HPA axis in depression: An overview of participation and relationship19
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants19
Correlation between S100B and severity of depression in MDD: A meta-analysis16
Circulating cell-free mitochondrial DNA in brain health and disease: A systematic review and meta-analysis16
Oral ketamine for depression: An updated systematic review15
Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependence14
Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder14
Transcriptomic profiling as biological markers of depression – A pilot study in unipolar and bipolar women14
Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition14
Circulating inflammatory markers, cell-free mitochondrial DNA, cortisol, endocannabinoids, and N-acylethanolamines in female depressed outpatients14
Sleep-related traits and attention-deficit/hyperactivity disorder comorbidity: Shared genetic risk factors, molecular mechanisms, and causal effects14
The similar eye movement dysfunction between major depressive disorder, bipolar depression and bipolar mania13
Spend time outdoors for your brain – an in-depth longitudinal MRI study13
Growth factors in anorexia nervosa: a systematic review and meta-analysis of cross-sectional and longitudinal data12
Malignant catatonia: Severity, treatment and outcome – a systematic case series analysis11
Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia11
Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids11
Severe mental disorders and vaccinations – a systematic review11
Mitochondria’s role in sleep: Novel insights from sleep deprivation and restriction studies11
The value of ‘mega cohorts’ for psychiatric research10
Effects of low-dose alcohol exposure in adolescence on subsequent alcohol drinking in adulthood in a rat model of depression10
Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer’s disease10
SNX29, a new susceptibility gene shared with major mental disorders in Han Chinese population10
Targeted sequencing approach: Comprehensive analysis of DNA methylation and gene expression across blood and brain regions in suicide victims10
The assessment of childhood maltreatment and its associations with affective symptoms in adulthood: Results of the German National Cohort (NAKO)10
Altered expression levels of miR-144-3p and ATP1B2 are associated with schizophrenia9
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis9
Effects of testosterone suppression on desire, hypersexuality, and sexual interest in children in men with pedophilic disorder8
Metabolic syndrome components and leukocyte telomere length in patients with major depressive disorder8
Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder8
Generalised anxiety and panic symptoms in the German National Cohort (NAKO)8
Newborn differential DNA methylation and subcortical brain volumes as early signs of severe neurodevelopmental delay in a South African Birth Cohort Study8
Genetic variants in miRNAs differentially expressed during brain development and their relevance to psychiatric disorders susceptibility8
Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: A systematic review8
Amygdala structure and function in paediatric bipolar disorder and high-risk youth: A systematic review of magnetic resonance imaging findings8
Handedness as a neurodevelopmental marker in schizophrenia: Results from the FACE-SZ cohort8
The assessment of cognitive function in the German National Cohort (NAKO) – Associations of demographics and psychiatric symptoms with cognitive test performance7
The potential of biomarkers for diagnosing insomnia: Consensus statement of the WFSBP Task Force on Sleep Disorders7
Volatile organic compounds from exhaled breath in schizophrenia7
Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials7
Autonomic nervous system activity and dialectical behavioral therapy outcome in adolescent borderline personality pathology7
Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study7
Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: A retrospective analysis of 54 samples7
0.027500152587891